Evidence map›Paper›PMID 36143473›Full record

ArticleLife (Basel, Switzerland)2022

H

Ce Chen, Mingyue He, Xueting Li, Lidong Yu, Yi Liu, Yan Yang, Li Li, Jianbo Jia, Bingsheng Li

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ce ChenSchool of Life Science and Technology, Harbin Institute of Technology, Harbin 150080, China.
Mingyue HeSchool of Life Science and Technology, Harbin Institute of Technology, Harbin 150080, China.
Xueting LiSchool of Life Science and Technology, Harbin Institute of Technology, Harbin 150080, China.
Lidong YuSchool of Physics, Harbin Institute of Technology, Harbin 150080, China.
Yi LiuSchool of Life Science and Technology, Harbin Institute of Technology, Harbin 150080, China.
Yan YangSchool of Life Science and Technology, Harbin Institute of Technology, Harbin 150080, China.
Li LiSchool of Life Science and Technology, Harbin Institute of Technology, Harbin 150080, China.ORCID 0000-0002-3414-5561
Jianbo JiaSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China.ORCID 0000-0003-0671-1527
Bingsheng LiKey Laboratory of UV Light Emitting Materials and Technology of Ministry of Education, Northeast Normal University, Changchun 130024, China.ORCID 0000-0001-5199-6395
Harbin Institute of Technology · CNNortheast Normal University · CNWuyi University · CN

Funding

National Key Technologies R&D Program of China 2019YFA0705202the National Natural Science Foundation of China 31701296 and 11474076
6 · The paper itself

Abstract

The Nrf2/ARE signaling pathway is a cell survival response pathway in response to environmental stresses. The Nrf2/ARE signaling pathway can be activated by stimulating cysteine residues at different positions in the Keap1. However, the epigenetic mechanisms of the Nrf2/ARE pathway under different stimuli are still poorly understood. In this study, we found that both hydrogen peroxide (H

Indexed as

methylation regulationNrf2/ARE signaling pathwayoxidative stresszebrafish

Identifiers

PMID36143473
PMCPMC9503143
OpenAlexW4296241792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.